Walleye Trading LLC Karyopharm Therapeutics Inc. Transaction History

Walleye Trading LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.08 - $5.82 $242,678 - $346,173	59,480 New	59,480 $325,000
Q2 2022 Aug 08, 2022	SELL	$4.15 - $8.37 $109,900 - $221,654	-26,482 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.91 - $14.38 $102,739 - $249,981	17,384 Added 191.07%	26,482 $195,000
Q4 2021 Feb 14, 2022	SELL	$5.21 - $8.61 $226,728 - $374,689	-43,518 Reduced 82.71%	9,098 $59,000
Q4 2019 Feb 14, 2020	BUY	$9.23 - $19.67 $485,645 - $1.03 Million	52,616 New	52,616 $1.01 Million

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $67M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.